Rare diseases
Investigational molecules
Locations
9704 Medical Center Drive, 20850-3343, United States
Macrogenics Inc. focuses on clinical research in metastatic castration-resistant prostate cancer, with studies centered on treatment options for advanced disease that no longer responds to standard hormone suppression.
The sponsor’s trial portfolio in this area examines disease control and progression outcomes in patients with difficult-to-treat prostate cancer.
Macrogenics Inc. runs clinical trials in conditions such as Hormone-refractory prostate cancer, Prostate cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
